Companies Announce Positive Preliminary Results From Coronavirus Vaccine Candidate Phase 1/2 Study

July 09, 2020

Pulmonology Advisor (7/8, Park) reports, “Pfizer and BioNTech SE announced positive preliminary results from the phase 1/2 study evaluating the safety, tolerability, and immunogenicity of escalating doses of the vaccine candidate BNT162b1 against coronavi...